title: Active immunization in HIV-infected patients.
abstract: Patients infected with human immunodeficiency virus (HIV) are at risk for various viral and bacterial infections. Active immunization with currently available vaccines may reduce the risk of some vaccine-preventable diseases in this population. Based on available data, most vaccines used in the United States are safe in HIV-infected adults and children. Their clinical efficacy in these individuals is not well defined, although it appears that patients in the earlier stages of infection are more likely to mount a protective antibody response than those in the later stages. Current guidelines for vaccination in HIV-infected children and adults in the United States have been recommended by the Advisory Committee on Immunization Practices.
authors.affiliation: Department of Pharmacy Practice, College of Pharmacy, Chicago, Illinois 60612, USA.
authors.forename: A K
authors.initials: AK
authors.lastname: Pau
authors.forename: I R
authors.initials: IR
authors.lastname: McNicholl
authors.forename: K J
authors.initials: KJ
authors.lastname: Pursell
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000517:prevention & control*; D000367:Age Factors; D002648:Child; D002675:Child, Preschool; D018073:Haemophilus Vaccines / Q000627:therapeutic use; D006509:Hepatitis B / Q000517:prevention & control; D017325:Hepatitis B Vaccines / Q000627:therapeutic use; D006801:Humans; D007252:Influenza Vaccines / Q000627:therapeutic use; D011008:Pneumococcal Infections / Q000517:prevention & control; D014611:Vaccination / Q000009:adverse effects
chemical_list: D018073:Haemophilus Vaccines; D017325:Hepatitis B Vaccines; D007252:Influenza Vaccines